Despite being a chronic condition, like diabetes or cardiovascular disease, osteoarthritis isn’t treated as such, says Joanne M. Jordan, MD, director of the University of North Carolina's Thurston Arthritis Research Center.
According to the authors of a recent study, almost 50% of patients with end-stage renal disease (ESRD) say they have chronic pain, and over 75% of them rate it as being moderate to severe.
While many of the current treatments for osteoarthritis influence symptoms, the future needs to lean toward finding disease-modifying treatments, according to Joanne M. Jordan, MD.
A clinical diagnosis of osteoarthritis is made by physicians based on an examination of a patient’s joints. Rather than getting X-rays, physicians more likely rule out other things that are going on, according to Joanne M. Jordan, MD.
Although change in knee joint space narrowing depicted on radiographs is considered the gold standard for monitoring osteoarthritis progression and knee cartilage volume loss, the method doesn’t account for extrusion of the medial meniscus, which new research suggests can better predict radiographic osteoarthritis change over time.
Though previous reports have described a link between vitamin D deficiency and an increased risk of rheumatoid arthritis (RA) development, a trio of studies has now offered clinical support to the contrary belief.